Navigation Links
Cymbet EnerChip Solid State Batteries Verified 100% Biocompatible
Date:5/13/2013

Nuremberg, Germany (PRWEB) May 14, 2013

Cymbet Corporation announced today at the PCIM Europe show the successful results of in vivo biocompatibility feasibility studies that were conducted to evaluate the biological safety of the EnerChip™ Rechargeable Solid State Battery. EnerChip bare die batteries were crushed and combined into a saline solution which was introduced into an in vivo test setting. No ill effects were recorded nor were any test article related lesions observed in this study.

These excellent in vivo test results reinforce similar findings from Cymbet’s July 2012 in vitro studies in which EnerChip bare die battery samples were gamma sterilized and evaluated using two in vitro test methods for cytotoxicity and the EnerChips demonstrated 100% non-cytotoxicity.

Cymbet EnerChip solid state batteries are uniquely fabricated using standard semiconductor manufacturing processes using patented construction techniques. One of the most rigorous ways to test the intrinsic biological safety of the EnerChip battery is to introduce crushed EnerChip bare die into in vivo test settings. Crushing the battery replicates the case of an EnerChip-powered implanted medical device that is catastrophically destroyed. In this trauma situation, the EnerChip battery components would be exposed directly to the in vivo setting. The results of this in vivo testing showed no harmful effects from having the crushed EnerChips in the body.

EnerChip Solid State Batteries are uniquely safe for use in new product designs. EnerChip batteries have the same handling and die attach mechanisms as the other Integrated Circuits found in electronic devices. This makes EnerChips ideal for co-packaging with other ICs to create advanced Systems-in-Package (SIP) devices. EnerChips are also packaged in standard plastic DFN semiconductor packages that ship on tape and reel. There are many global environmental and safety standards and directives that cover batteries. EnerChip solid state batteries are the ideal solution as they address: RoHS, China RoHS, REACH, CE Mark, UL-Underwriters Laboratory, JEDEC IC Packaging Standards, IEC, NEMA/ANSI, UN Air Safety Regulations, WEEE Directive, Battery Directive, MSDS and OSHA Information, End-of-Life Disposal Instructions and Biocompatibility Standards.

For more information on environmental standards and eco-friendly features please download this EnerChip Product Information Brief at: http://www.cymbet.com/pdfs/PI-72-04.pdf.

EnerChip rechargeable solid state batteries are available from Cymbet global distribution partners including: Avnet Abacus, Farnell, Element14, RS, DigiKey, Mouser and others.

About Cymbet
Cymbet Corporation is the leader in solid state energy storage technology. The company is the first to market eco-friendly rechargeable storage devices that provide embedded systems designers with new embedded energy capabilities. The company's EnerChip™ solid state batteries with integrated power management enable new concepts in energy storage application for ICs and new products for medical, sensor, RFID, industrial control, communications and portable electronic devices. Visit Cymbet online at http://www.cymbet.com.

Read the full story at http://www.prweb.com/releases/2013/5/prweb10705598.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related medicine news :

1. Cymbet Secures $20 Million Investment
2. Smith & Nephew Hip Recall News: Bernstein Liebhard LLP Notes Motion to Consolidate Smith & Nephew Lawsuits Filed in Tennessee State Courts
3. Solid-state controllable light filter may protect preterm infants from disturbing light
4. Transvaginal Mesh Complications Lawsuits Update: Resource4thePeople Reports Some CasesDismissed from Consolidated Litigation
5. New Instrument for High-Precision Measurements of Soy Milk Solids and Protein Concentration
6. Consolidated Facility Advises Spring Cleaning Done Now in Davis Businesses
7. AACR: Positive data supports advancing BIND-014 to phase 2 clinical trials for solid tumors
8. Researchers to develop next generation immunotherapy for children with deadly solid tumors
9. Four in 10 Babies Given Solid Foods Too Early, Study Finds
10. Sleep consolidates memories for competing tasks
11. Accelerated Debt Consolidation, Inc. Offers Tips to Help Determine if Consumers are Heading Toward Financial Problems; New Statistical Data Shows Increased Delinquencies
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/24/2017)... ... May 24, 2017 , ... Technique, technique, technique – with a ... lifting weights for strength training and exercise or simply lifting heavy objects, advises Dr. ... position is everything,” Dr. Chang says. “Improper technique in lifting anything heavy or an ...
(Date:5/23/2017)... New York City (PRWEB) , ... May 23, ... ... Record (EHR), Population Health and Clinical Integration company, announced today that its ... Patient-Centered Medical Home (PCMH) 2017 Prevalidation. NCQA recently introduced PCMH 2017 standards ...
(Date:5/23/2017)... ... May 23, 2017 , ... Allegheny Health Network and the ... Center for Women’s Behavioral Health at West Penn Hospital , a unique facility ... suffering from pregnancy-related depression. Construction of the Center is underway with a scheduled ...
(Date:5/23/2017)... ... 2017 , ... Cambridge, MA, May 23, 2017—Total costs per ... a Workers Compensation Research Institute (WCRI) study, a contrast from the increases of ... Benchmarks, 17th Edition looks at indemnity and medical payments for workers’ compensation ...
(Date:5/23/2017)... ... May 23, 2017 , ... i2i ... 2017 Best in KLAS category winner, has named Daniel P. Bullington as chief ... enhance its technology platform and product offerings,” says Justin Neece, president. “Daniel is ...
Breaking Medicine News(10 mins):
(Date:5/18/2017)... 18, 2017  Two Bayer U.S. Pharmaceutical leaders received ... its recent 28 th Woman of the ... showcases HBA,s longstanding mission of furthering the advancement and ... Cindy Powell-Steffen , senior director of brand ... and Libby Howe , a regional business manager ...
(Date:5/15/2017)... Enterin Inc., a privately-held CNS pharmaceutical company based ... to treat Parkinson,s disease (PD), has enrolled the first patient ... randomized, controlled, multicenter study involving patients with PD and taking ... over a 9-to-12-month period. The first stage is open label ... Participating sites include Denver , ...
(Date:5/10/2017)... May 10, 2017 Hologic, Inc. (Nasdaq: ... for the fiscal second quarter ended April 1, 2017 ... $1.84 increased 666.7% compared to the prior year period ... in a significant gain, while non-GAAP diluted EPS of ... or 3.8% in constant currency terms.  Excluding the effects ...
Breaking Medicine Technology: